Trial Profile
Prospective observational study of relapsed and refractory pediatric acute lymphoblastic leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 May 2021
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Pharmacodynamics; Therapeutic Use
- 25 May 2021 Status changed from active, no longer recruiting to completed.
- 24 May 2019 Status changed from recruiting to active, no longer recruiting.
- 15 Dec 2015 New trial record